Brellium is an AI-powered clinical note auditor that conducts note audits according to customized clinical and billing standards.
Brellium has raised $16.7M in total funding. The most recent round was Series A. The last funding was announced in March 2025.
Brellium's investors include Menlo Ventures, First Round Capital, Fiat Ventures, Left Lane Capital, Cory Levy.
Brellium is headquartered in New York, United States.
Brellium is an AI-powered clinical note auditor that conducts note audits according to customized clinical and billing standards.
Brellium is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Brellium — Funding & Investors." VCBacked, March 17, 2025, https://www.vcbacked.co/company/brellium. Accessed September 2, 2026.
VCBacked. (2025). Brellium — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/brellium
{{cite web |title=Brellium — Funding & Investors |url=https://www.vcbacked.co/company/brellium |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated